Invasive Lobular Carcinoma vs. Invasive Ductal Carcinoma: Survival Comparison
Author Information
Author(s): S Toikkanen, L Pylkkanen, H Joensuu
Primary Institution: University Central Hospital of Turku
Hypothesis
Invasive lobular carcinoma (ILC) has better survival outcomes compared to invasive ductal carcinoma (IDC).
Conclusion
Women with invasive lobular carcinoma have better short- and long-term survival rates than those with invasive ductal carcinoma.
Supporting Evidence
- ILC patients had lower rates of axillary nodal metastases compared to IDC patients (43% vs 53%).
- 5- and 30-year corrected survival rates for ILC were 78% and 50%, respectively, compared to 63% and 37% for IDC.
- ILCs were more frequently of low grade and had lower mitotic counts than IDCs.
Takeaway
This study found that women with a type of breast cancer called lobular carcinoma tend to live longer than those with ductal carcinoma.
Methodology
The study compared outcomes and prognostic factors of 217 women with invasive lobular carcinoma and 1121 women with invasive ductal carcinoma, following them for 10-43 years.
Limitations
The study is retrospective and may be limited by the accuracy of historical data and classification.
Participant Demographics
All participants were female patients diagnosed with invasive breast cancer in Turku, Finland.
Statistical Information
P-Value
P=0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website